Poison Pill

Defense against a hostile acquisition which enacted by the board of directors provides shareholder the right to purchase common shares at a nominal cost upon the occurrence of a triggering event such as the acquisition of more than 10% of the company’s shares by a single party, partnership, or group.

Post to Twitter  Post to Facebook  Post to StumbleUpon

About the Author

Will Dearman is the Editor of TheStrategyBlog. His professional experience includes acquiring and later selling a portfolio of Internet-based companies as well as working as a credit underwriter in Bank of America's commercial middle market bank. His interests include finance, innovation, strategy and social technology. Find him on Twitter!